Published in JAMA on September 18, 1996
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02
Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect (2010) 3.35
Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci (2005) 2.61
Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev (1999) 2.55
Preventing and treating hepatitis B infection. BMJ (2004) 1.80
Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ (2002) 1.52
Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut (2004) 1.42
An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis. Environ Health Perspect (1998) 1.27
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer (2007) 1.21
Epidemiology of hepatitis B virus infection in Albania. World J Gastroenterol (2009) 1.05
Hepatitis B virus: where do we stand and what is the next step for eradication? World J Gastroenterol (2014) 1.03
Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation. PLoS One (2012) 1.02
The role of aflatoxins in hepatocellular carcinoma. Hepat Mon (2012) 1.01
Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2010) 0.98
Seroepidemiology of HBV infection in South Korea, 1995 through 1999. Korean J Intern Med (2001) 0.90
Molecular cancer prevention: Current status and future directions. CA Cancer J Clin (2015) 0.86
Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents. Hum Vaccin Immunother (2013) 0.84
Comparison of childhood hepatic malignancies in a hepatitis B hyper-endemic area. World J Gastroenterol (2005) 0.84
Natural history of chronic hepatitis B virus infection. Med Microbiol Immunol (2014) 0.84
Optimisation of prime-boost immunization in mice using novel protein-based and recombinant vaccinia (Tiantan)-based HBV vaccine. PLoS One (2012) 0.83
Geographic patterns of hepatocellular carcinoma mortality with exposure to iron in groundwater in Taiwanese population: an ecological study. BMC Public Health (2013) 0.82
Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents. Hum Genet (2013) 0.81
Hepatitis B vaccination in preterm infants. Arch Dis Child Fetal Neonatal Ed (1997) 0.81
Gestational zinc deficiency impairs humoral and cellular immune responses to hepatitis B vaccination in offspring mice. PLoS One (2013) 0.79
Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? Insights Imaging (2010) 0.78
HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy. Genes Immun (2013) 0.77
Future perspectives for hepatocellular carcinoma. HPB (Oxford) (2003) 0.76
Infantile hepatitis B in immunized children: risk for fulminant hepatitis and long-term outcomes. PLoS One (2014) 0.76
Prevention of hepatitis B. Cold Spring Harb Perspect Med (2015) 0.76
Infection with hepatitis B virus carrying novel pre-S/S gene mutations in female siblings vaccinated at birth: two case reports. J Med Case Rep (2010) 0.76
Emerging hepatitis B virus infection in vaccinated populations: a rising concern? Emerg Microbes Infect (2012) 0.76
Five-Year Eradication of Hepatitis B Infection After an Outreach Immunization Program in the Waorani Population in the Ecuadorian Amazon. Am J Trop Med Hyg (2016) 0.75
Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study. BMC Public Health (2014) 0.75
Success of mass vaccination of infants against hepatitis B. JAMA (1996) 0.75
Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med (1997) 6.03
Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology (2000) 4.97
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology (1994) 4.01
Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci U S A (1991) 3.82
The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc Natl Acad Sci U S A (1991) 3.52
Use of a snake venom toxin to characterize the cholinergic receptor protein. Proc Natl Acad Sci U S A (1970) 3.48
Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet (1999) 3.02
Hepatitis B genotypes and the response to interferon therapy. J Hepatol (2000) 2.97
Dynamical theory of activated processes in globular proteins. Proc Natl Acad Sci U S A (1982) 2.94
The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5' termini of viral genomic and antigenomic RNA. Virology (1992) 2.88
Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family. Mol Cell Biol (1990) 2.78
The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes. Microbiology (1997) 2.61
Molecular characterization and transcriptional analysis of type 8 capsule genes in Staphylococcus aureus. J Bacteriol (1997) 2.58
Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med (2001) 2.55
Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus. J Bacteriol (1994) 2.54
Chorea-ballismus with nonketotic hyperglycemia in primary diabetes mellitus. AJNR Am J Neuroradiol (1996) 2.54
MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood (2001) 2.44
Antioxidant activity of fresh apples. Nature (2000) 2.40
Seventh cervical nerve root transfer from the contralateral healthy side for treatment of brachial plexus root avulsion. J Hand Surg Br (1992) 2.30
The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol (1996) 2.30
Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis (1990) 2.30
Sequence determination and comparison of the exfoliative toxin A and toxin B genes from Staphylococcus aureus. J Bacteriol (1987) 2.25
Lysogenic conversion of staphylococcal lipase is caused by insertion of the bacteriophage L54a genome into the lipase structural gene. J Bacteriol (1986) 2.24
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest (1992) 2.20
Influence of denervation on localization of neurotoxins from clapid venoms in rat diaphragm. Nature (1967) 2.18
Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. J Hepatol (1996) 2.15
Chromatographic separation of the venom of Bungarus multicinctus and characterization of its components. J Chromatogr (1972) 2.00
Human herpesvirus-6 associated with fatal haemophagocytic syndrome. Lancet (1990) 1.99
Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery (1986) 1.98
Integration of staphylococcal phage L54a occurs by site-specific recombination: structural analysis of the attachment sites. Proc Natl Acad Sci U S A (1986) 1.88
A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA (1987) 1.83
Chemistry and pharmacology of polypeptide toxins in snake venoms. Annu Rev Pharmacol (1972) 1.79
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
Assessing pollution prevention program by QUAL2E simulation analysis for the Kao-Ping River Basin, Taiwan. J Environ Manage (2001) 1.77
Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol (1991) 1.74
Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol (1992) 1.73
Differential diagnosis of extrahepatic biliary atresia from neonatal hepatitis: a prospective study. J Pediatr Gastroenterol Nutr (1994) 1.73
Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology (1985) 1.73
Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology (1999) 1.69
Nucleotide sequence and genetic characterization of staphylococcal bacteriophage L54a int and xis genes. J Bacteriol (1989) 1.68
Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr (1995) 1.67
Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles. J Virol (1991) 1.67
Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr (2001) 1.64
Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology (1992) 1.64
Incidence and characterization of Bacillus cereus isolates contaminating dairy products. Appl Environ Microbiol (1988) 1.63
GBV-C in the aetiology of fulminant hepatitis. Lancet (1996) 1.61
Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol (1985) (1995) 1.61
Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr (1993) 1.61
Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J Hepatol (1987) 1.59
A Shannon entropy analysis of immunoglobulin and T cell receptor. Mol Immunol (1997) 1.58
Transmission of hepatitis C virus between spouses: the important role of exposure duration. Am J Gastroenterol (1996) 1.58
Modes of actions of purified toxins from elapid venoms on neuromuscular transmission. Mem Inst Butantan (1966) 1.56
Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol (1995) 1.56
Histiocytic medullary reticulosis: a lethal form of primary EBV infection in young children in Taiwan. Lancet (1989) 1.56
A common structural unit in asparagine-oligosaccharides of several glycoproteins from different sources. J Biol Chem (1972) 1.54
Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine. Hum Gene Ther (2000) 1.53
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience. J Gastroenterol Hepatol (2001) 1.52
Primary human herpesvirus 6 infections in children: a prospective serologic study. J Infect Dis (1992) 1.50
Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology (1993) 1.50
Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis (1992) 1.49
Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. J Pediatr (2000) 1.49
Sexual transmission of HCV. Lancet (1993) 1.49
Factors affecting the collagen binding capacity of Staphylococcus aureus. Infect Immun (1998) 1.48
Mechanism of bacteriophage conversion of lipase activity in Staphylococcus aureus. J Bacteriol (1985) 1.47
Neonatal Dubin-Johnson syndrome. J Pediatr Gastroenterol Nutr (1994) 1.44
Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol (1986) 1.44
Sequence analysis and comparison of int and xis genes from staphylococcal bacteriophages L54a and phi 11. J Bacteriol (1990) 1.43
Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer (1985) 1.43
Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology (1984) 1.41
Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene (1998) 1.40
Studies of the presynaptic effect of -bungarotoxin on neuromuscular transmission. J Pharmacol Exp Ther (1973) 1.39
WHO rejects Taiwan as observer. Lancet (1997) 1.38
A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation (1997) 1.38
Metastasis of hepatocellular carcinoma to the heart: unusual patterns in three cases with antemortem diagnosis. J Formos Med Assoc (1992) 1.37
Helicobacter pylori acquisition in infancy after decline of maternal passive immunity. Pediatr Res (1997) 1.37
Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology (1996) 1.36
Amino acid sequence of -bungarotoxin from the venom of Bungarus multicinctus. Biochem Biophys Res Commun (1971) 1.36
Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem (2000) 1.36
Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA (2000) 1.33